华峰化学(002064) - 2024 Q2 - 季度业绩预告

Financial Performance Expectations - The company expects a net profit attributable to shareholders of between RMB 138 million and RMB 168 million for the first half of 2024, representing a year-on-year increase of 1.57% to 23.65%[2] - The net profit after deducting non-recurring gains and losses is projected to be between RMB 132.5 million and RMB 162.5 million, reflecting a year-on-year growth of 1.35% to 24.30%[2] - Basic earnings per share are anticipated to be between RMB 0.28 and RMB 0.34, compared to RMB 0.27 per share in the same period last year[2] Production and Profitability - The company has experienced capacity release in its spandex and adipic acid segments, leading to an increase in production and sales volume compared to the same period last year[2] - The gross profit margin has remained stable compared to the previous year, contributing to the overall improvement in profitability[2] Forecast and Risk Disclosure - The performance forecast is based on preliminary estimates by the company's finance department and has not been audited by an accounting firm[3] - The specific financial data will be disclosed in the company's 2024 semi-annual report, and investors are advised to invest rationally and be aware of risks[3]